BridgeBio Oncology Therapeutics, Inc. — 8-K Filings
13 8-K filings on record
This page lists all 8-K filings submitted to the SEC by BridgeBio Oncology Therapeutics, Inc. (BBOT), sorted by most recent first. Each row links to the full filing on EdgarLookup. BridgeBio Oncology Therapeutics, Inc. has filed 13 8-K documents with the SEC since 2023. To view all SEC filings by BridgeBio Oncology Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
3
4
424B3
424B4
425
8-A12B
8-K
CERT
CORRESP
DRS
DRS/A
DRSLTR
EFFECT
POS AM
S-1
S-1/A
S-1MEF
S-4
S-4/A
S-8
SC 13D
SC 13G
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | 8-K | 0001193125-26-126493 | Mar 26, 2026 | Mar 24, 2026 |
| 8-K | 8-K | 0001193125-26-093997 | Mar 5, 2026 | — |
| 8-K | 8-K | 0001193125-26-005425 | Jan 7, 2026 | — |
| 8-K | 8-K | 0001193125-25-277601 | Nov 12, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-075190 | Aug 13, 2025 | Aug 11, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-072312 | Aug 6, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-071392 | Aug 4, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-062955 | Jul 11, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-018997 | Mar 3, 2025 | Feb 28, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-018334 | Feb 28, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-011454 | Feb 10, 2025 | Feb 8, 2025 |
| 8-K | CURRENT REPORT | 0001213900-24-015329 | Feb 20, 2024 | Feb 13, 2024 |
| 8-K | CURRENT REPORT | 0001213900-24-013637 | Feb 14, 2024 | Feb 8, 2024 |